Welcome to our dedicated page for Radnet news (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet stock.
RadNet, Inc. (NASDAQ: RDNT) generates a steady flow of news as a national provider of freestanding, fixed-site diagnostic imaging services and as the parent of DeepHealth, its AI-powered health informatics division. News about RadNet often highlights developments across its network of 407 owned and/or operated outpatient imaging centers in markets such as Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas, as well as updates from its Digital Health segment.
Investors and observers following RDNT news will encounter announcements on topics such as acquisitions of imaging centers, expansion into new regional markets and updates on RadNet’s operational performance. For example, the company has reported acquisitions like Radiology Regional in Southwest Florida, adding multiple imaging centers and staff to its Florida footprint. Earnings releases and financial guidance updates are also frequent news items, reflecting trends in imaging volumes, segment revenue and Adjusted EBITDA for both the Imaging Center and Digital Health segments.
RadNet’s DeepHealth division is another major source of news, with press releases covering the launch of AI-powered clinical suites, imaging informatics platforms and collaborations with partners. Recent communications have described products such as Breast Suite, Thyroid Suite, Operations Suite, Diagnostic Suite and TechLive, as well as research findings published in scientific journals and showcased at industry conferences like RSNA. News may also cover strategic collaborations, including letters of intent and partnerships with companies such as GE HealthCare to expand AI-powered imaging solutions across modalities and geographies.
Because RadNet regularly issues updates on its financial results, acquisitions, digital health initiatives and research milestones, the RDNT news page can be a useful resource for tracking how the company’s imaging center operations and DeepHealth portfolio evolve over time. Readers interested in diagnostic imaging services, AI in radiology and healthcare operations technology may find RadNet’s news particularly relevant.
RadNet, a national leader in diagnostic imaging services, announced that Mark Stolper, Executive Vice President and CFO, will present at the Sidoti & Company Spring 2023 Conference on March 22, 2023, at 1:00 p.m. Eastern Time. The event will be accessible via live and archived webcasts on their website and the provided link. RadNet operates 357 outpatient imaging centers across several states, employing over 9,000 personnel. As a top provider of fixed-site diagnostic imaging services in the U.S., RadNet focuses on delivering high-quality, cost-effective solutions.
RadNet, a leader in diagnostic imaging services, announced that Mark Stolper, CFO, will present at the Barclays Global Healthcare Conference on March 16, 2023, at 9:30 a.m. ET (6:30 a.m. PT). The location is the Loews Miami Beach Hotel. Interested parties can access the presentation via live and archived webcasts on their website and through the provided URL. RadNet operates a vast network of 357 outpatient imaging centers in key states like California and New York, employing over 9,000 staff to provide top-quality, cost-effective services.
RadNet, a leading provider of diagnostic imaging services in the U.S., will have Mark Stolper, CFO, and Gregory Sorensen, CEO of DeepHealth, present at the Cowen & Company Healthcare Conference on March 7, 2023, at 9:50 a.m. Eastern Time. The presentation will highlight RadNet's advancements in imaging technology and artificial intelligence. Interested parties can access live and archived webcasts at https://wsw.com/webcast/cowen132/rdnt/2026416 and through the RadNet website under the News section. As of now, RadNet operates 357 imaging centers across several states with over 9,000 employees.
RadNet (NASDAQ: RDNT) reported a 15.2% increase in revenue for Q4 2022, reaching $383.9 million, compared to $333.1 million in Q4 2021. Excluding the AI segment, revenue from Imaging Centers grew 15.1%, totaling $382.5 million. Adjusted EBITDA rose 18.4% to $61.6 million. The company announced guidance for 2023, projecting revenue between $1.525 billion and $1.575 billion, with a growth rate of 7%-10%. RadNet is also expanding its AI-powered breast cancer detection services, predicting that losses from the AI segment will decrease significantly in 2023, potentially turning profitable in 2024.
RadNet, Inc. (NASDAQ: RDNT) will host a conference call on February 28, 2023, at 7:30 a.m. PT to discuss its fourth quarter 2022 financial results. Investors can join the call by dialing 877-407-0789 (U.S.) or 201-689-8562 (international). The event will also be available via webcasts, with an archived replay accessible through designated dial-ins. RadNet is a leading provider of diagnostic imaging services in the U.S., operating 349 imaging centers across various states. The company specializes in radiology IT and AI solutions, teleradiology services, and employs approximately 9,000 individuals.
RadNet, Inc. (NASDAQ: RDNT) has initiated its Enhanced Breast Cancer Detection (EBCD) service, designed to improve breast cancer screening accuracy in New York and New Jersey. This service incorporates the Saige-Dx™ AI technology, an advanced tool for analyzing mammograms, alongside personalized lifetime risk assessments and a dedicated support line. EBCD aims to empower patients by offering more informative mammograms and addressing their concerns regarding breast cancer risk. The service is supported by extensive AI training on over one million images, enhancing radiologists’ efficiency and accuracy. RadNet continues to lead in AI-driven radiology solutions.
On February 6, 2023, RadNet (NASDAQ: RDNT) announced the launch of its Enhanced Breast Cancer Detection (EBCD) service. This innovative service integrates advanced AI technologies, including Saige-Dx™, to provide patients with enhanced mammography accuracy and personalized lifetime risk assessments for breast cancer. The program aims to improve early detection through AI-driven analysis and includes a support line for patient inquiries. According to company executives, the EBCD service enhances the quality of breast cancer screenings, ultimately aiming to improve patient outcomes.
RadNet announced that its subsidiary, DeepHealth, received FDA clearance for its AI mammography density assessment tool, Saige-Density™. This innovative software automates breast density categorization, aiding radiologists in detecting cancer more effectively. With nearly half of women over 40 classified as having dense breast tissue, this tool is crucial for accurate evaluations, especially as many states mandate breast density notifications. Saige-Density™ is the third AI product from DeepHealth to gain FDA approval, showcasing the company's commitment to enhancing mammography through advanced technology.
RadNet, a leader in diagnostic imaging services, announced that Chief Financial Officer Mark Stolper will present at the Sidoti & Company December 2022 Small-Cap Virtual Conference. The presentation is scheduled for December 7, 2022, at 3:15 PM Eastern Time. Attendees can access the live and archived webcasts on RadNet's website under the 'About RadNet' section and on the Sidoti platform. RadNet operates 349 outpatient imaging centers across several states, employing about 9,000 individuals.
Delaware Imaging Network, part of RadNet (NASDAQ: RDNT), has launched the Enhanced Breast Cancer Detection (EBCD) service to improve mammography accuracy. This new service uses advanced AI technologies, including Saige-Dx™, to assist in breast cancer screenings. Key features include AI-driven reviews, comprehensive risk assessments, and a dedicated support line. This initiative aims to empower women with better health information and potentially improve patient outcomes. Dr. Berger emphasized EBCD as a significant advancement in patient care, positioning RadNet at the forefront of radiology innovation.
FAQ
What is the current stock price of Radnet (RDNT)?
What is the market cap of Radnet (RDNT)?
